Simultaneously, the in vivo transplantation results have also enlightened the prospect of SCAP-Ss as an effective therapeutic intervention for liverish patients with multiple manifestation of metabolic syndrome with poor disability and outcome including cirrhosis and fibrosis. Here, SCAP is linked to Cirrhosis.